Form 8-K - Current report:
SEC Accession No. 0001493152-24-025431
Filing Date
2024-06-27
Accepted
2024-06-27 16:06:19
Documents
14
Period of Report
2024-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 58358
2 ex10-1.htm EX-10.1 140136
  Complete submission text file 0001493152-24-025431.txt   397295

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE orgs-20240627.xsd EX-101.SCH 3018
4 XBRL LABEL FILE orgs-20240627_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE orgs-20240627_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3535
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

EIN.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 241079181
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)